CVS HEALTH CORPORATION - CVS STOCK NEWS

CVS Health announced a new #OneStepCloser sweepstakes, starting June 1, 2021, for customers who have received or will receive a COVID-19 vaccination through their services. Participants can win weekly and grand prizes totaling over a thousand rewards, including cruises and Super Bowl tickets, aimed at encouraging vaccination. More than 17 million doses have been administered nationwide, with CVS locations easily accessible to 85% of the U.S. population. The sweepstakes ends July 10.

CVS Health Corporation (NYSE: CVS) announced that CEO Karen Lynch will participate in a fireside chat with investors at the Goldman Sachs 42nd Annual Healthcare Conference on June 9, 2020, at approximately 10:30 am EST. CVS Health is a diversified health services company with over 300,000 employees, focused on improving healthcare accessibility and affordability through innovative services like HealthHUB locations.

For more information about CVS Health, visit investors.cvshealth.com.

CVS Health (NYSE: CVS) has launched a new Clinical Trial Services business aimed at improving access to clinical trials, a sector where traditional enrollment has been low. The initiative addresses challenges such as participant engagement and retention, exacerbated by the COVID-19 pandemic. Key capabilities include precision patient recruitment, innovative clinical trial delivery, and real-world evidence generation. This move builds on CVS's previous experience with COVID-19 vaccine trials, where over 300,000 volunteers were engaged. The initiative aims to enhance efficiency and participant experience.

CVS Health has appointed Shawn Guertin as the new Chief Financial Officer, effective May 28, 2021. Guertin, previously with Aetna, brings extensive experience in financial strategies and healthcare transformation. He succeeds Eva Boratto, who served successfully for 11 years. CVS Health reaffirms its full-year 2021 guidance, with an Adjusted EPS forecast of $7.56 to $7.68 and cash flow from operations projected at $12.0 to $12.5 billion. The company aims to achieve a low 3x leverage ratio by 2022, emphasizing growth and stability.

CVS Health announced that COVID-19 vaccine appointments for adolescents aged 12 to 15 are now available at over 5,600 CVS Pharmacy locations nationwide, following FDA Emergency Use Authorization for the Pfizer-BioNTech vaccine. Starting May 13, 2021, eligible adolescents can receive the vaccine with parental consent. CVS has administered over 17 million vaccines and plans to offer services at over 9,600 locations by May 16, 2021. The company's Return Ready program will also provide on-site vaccination clinics for larger organizations.

CVS Pharmacy announces an upgrade to its CarePass membership, now offering free same-day prescription delivery for eligible members through a partnership with Shipt. This enhancement allows members to receive prescriptions within hours and adds access to everyday wellness essentials. CarePass members also benefit from a 24/7 pharmacist helpline, discounts on CVS Health products, and a monthly $10 Promo Reward. The program launched nationally in August 2019 and costs $5 per month or $48 annually. Same-day delivery is available at nearly 8,000 CVS stores across 47 states.

CVS Health announced it will begin administering COVID-19 vaccines at 19 select CVS Pharmacy locations in New Hampshire starting May 9, 2021. The vaccine will be available at no cost for patients with insurance and those uninsured through a federal program. Patients can utilize walk-in appointments or schedule same-day appointments via CVS.com. This initiative is part of the Federal Retail Pharmacy Program, which enables CVS to vaccinate communities across 50 states and other territories, ensuring over 70% of the U.S. population is within 5 miles of a CVS location.

CVS Health reported a strong performance for Q1 2021, with total revenues of $69.1 billion, a 3.5% increase year-over-year. The company achieved a GAAP diluted EPS of $1.68, up 9.8% from last year. Adjusted EPS also rose to $2.04, reflecting a 6.8% growth. The firm raised its full-year GAAP diluted EPS guidance to $6.24-$6.36 and Adjusted EPS to $7.56-$7.68. Notably, cash flow from operations reached $2.9 billion. CEO Karen S. Lynch emphasized the company's commitment to enhancing care delivery amidst ongoing recovery from the pandemic.

CVS Health has launched initiatives to enhance women's health during May, providing no-cost heart health screenings at MinuteClinic locations from May 9 to May 15. This effort aims to address the significant risk of heart disease among women. Additionally, CVS Pharmacy is offering discounts on women's wellness products through May 22. The company is also supporting the American Heart Association's Go Red for Women movement, raising nearly $20 million since 2017. These initiatives underline CVS Health's commitment to personalized women's health care.